# A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

> **NCT05893797** · NA · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 36 (actual)

## Conditions studied

- Type 1 Diabetes
- Type 2 Diabetes
- Type 2 Diabetes Treated With Insulin

## Interventions

- **DRUG:** Insulin Lispro
- **DEVICE:** Tempo Smart Button
- **DEVICE:** Dexcom G6 CGM
- **DEVICE:** Glooko Research Mobile App (RMA)

## Key facts

- **NCT ID:** NCT05893797
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-05
- **Primary completion:** 2024-09-16
- **Final completion:** 2024-09-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05893797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05893797, "A Study of LY8888AX in Participants Using a Connected Insulin Management Platform". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05893797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*